1. Home
  2. ENOV vs PRCT Comparison

ENOV vs PRCT Comparison

Compare ENOV & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • PRCT
  • Stock Information
  • Founded
  • ENOV 1995
  • PRCT 2009
  • Country
  • ENOV United States
  • PRCT United States
  • Employees
  • ENOV N/A
  • PRCT N/A
  • Industry
  • ENOV Fluid Controls
  • PRCT Medical Specialities
  • Sector
  • ENOV Industrials
  • PRCT Health Care
  • Exchange
  • ENOV Nasdaq
  • PRCT Nasdaq
  • Market Cap
  • ENOV 1.8B
  • PRCT 2.0B
  • IPO Year
  • ENOV 2008
  • PRCT 2021
  • Fundamental
  • Price
  • ENOV $28.47
  • PRCT $28.86
  • Analyst Decision
  • ENOV Strong Buy
  • PRCT Buy
  • Analyst Count
  • ENOV 6
  • PRCT 9
  • Target Price
  • ENOV $51.17
  • PRCT $63.50
  • AVG Volume (30 Days)
  • ENOV 830.1K
  • PRCT 1.6M
  • Earning Date
  • ENOV 11-06-2025
  • PRCT 11-04-2025
  • Dividend Yield
  • ENOV N/A
  • PRCT N/A
  • EPS Growth
  • ENOV N/A
  • PRCT N/A
  • EPS
  • ENOV N/A
  • PRCT N/A
  • Revenue
  • ENOV $2,233,266,000.00
  • PRCT $299,907,000.00
  • Revenue This Year
  • ENOV $9.13
  • PRCT $48.38
  • Revenue Next Year
  • ENOV $6.39
  • PRCT $30.87
  • P/E Ratio
  • ENOV N/A
  • PRCT N/A
  • Revenue Growth
  • ENOV 11.57
  • PRCT 50.07
  • 52 Week Low
  • ENOV $25.47
  • PRCT $28.87
  • 52 Week High
  • ENOV $49.75
  • PRCT $100.89
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 38.57
  • PRCT 29.52
  • Support Level
  • ENOV $27.52
  • PRCT $29.78
  • Resistance Level
  • ENOV $32.41
  • PRCT $32.52
  • Average True Range (ATR)
  • ENOV 1.46
  • PRCT 1.56
  • MACD
  • ENOV -0.21
  • PRCT -0.36
  • Stochastic Oscillator
  • ENOV 16.67
  • PRCT 1.45

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: